Management of Kidney Stones: Current Scenario and Future Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 741

Special Issue Editor

Special Issue Information

Dear Colleagues,

We are in the modern era of innovations, technological developments and minimisation in the field of urology. The management of kidney stone disease (KSD) has been revolutionised over these last two decades with the use of lasers, scopes and ancillary equipment. In addition, there has been more research on basic science related to stone disease with newer concepts around intrarenal temperature and pressure.

The role of minimally invasive surgical techniques with mini PCNL and endoscopic combined intrarenal surgery (ECIRS) has also evolved. Fragmentation devices have also become innovative. The management of ureteroscopy (URS) has now expanded to all patient groups too. There is an increasing emphasis on the role of suction in endourological procedures, while the quest for better intrarenal pressure and temperature monitoring continues. The use of thulium fiber laser (TFL), Moses technology and small disposable ureteroscopes all help in pushing the boundaries of ureteroscopy and percutaneous nephrolithotomy procedures. Endourological techniques have especially pushed the boundaries in the management of stones in special population groups such as pediatrics, stones in anomalous kidneys and in pregnancy.

New technological developments have also led to improvement in the quality of life (QoL), reduced hospital stay and a reduction in complication rates. The addition of artificial intelligence in endourology has also helped in improving outcomes with predictive models and outcome prediction.

This Special Issue will cover all issues related to current scenarios and future perspectives in the management of kidney stone disease.

Prof. Dr. Bhaskar K. Somani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endourology
  • ureteroscopy
  • percutaneous nephrolithotomy (PCNL)
  • laser
  • technology and AI
  • shockwave lithotripsy
  • intrarenal temperature and pressure
  • social media

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 1266 KiB  
Article
Monopolar Transurethral Enucleoresection of Prostate: Feasibility of Modified Nesbit’s Enucleoresection with Apical Release
by Nitesh Kumar and Bhaskar Somani
J. Clin. Med. 2024, 13(5), 1455; https://doi.org/10.3390/jcm13051455 - 2 Mar 2024
Viewed by 506
Abstract
Background: Transurethral resection of the prostate (TURP) has been the standard surgical treatment for Benign Hyperplasia of the Prostate (BPH) for decades. Our objective was to evaluate the outcome of our new technique: Monopolar Transurethral Enucleoresection of the Prostate (TUERP) with apical [...] Read more.
Background: Transurethral resection of the prostate (TURP) has been the standard surgical treatment for Benign Hyperplasia of the Prostate (BPH) for decades. Our objective was to evaluate the outcome of our new technique: Monopolar Transurethral Enucleoresection of the Prostate (TUERP) with apical release (bring it all to centre). Methods: A prospective study of all cases undergoing TUERP at a tertiary centre from January 2020 to October 2022 was performed. Patient demographics, intraoperative variables and postoperative results along with follow-up data were collected. Data of all the cases who had completed a one-year follow-up post-surgery were included and analysed. Results: A total of 240 patients with complete data including a one-year follow-up were included. Mean prostatic volume was 55.3 ± 11.6 gm, and 28 (11.67%) cases were >100 gm. The mean operative time was 31.7 ± 7.6, and mean haemoglobin drop at 24 h was 0.73 ± 1.21 gm/dL. The overall complication rate was 16.67%, with only two (0.83%) Clavien–Dindo III complications (haematuria and clots needing evacuation) and the other complications being Clavien–Dindo I/II complications. Sustained improvement at 1 year of follow-up was noted: Qmax: 25.2 ± 5.6 mL/s, IPSS: 4.7 ± 2.5 and PVR: 22.5 ± 9.6 mL. Conclusions: Monopolar TUERP with a modified Nesbit’s enucleoresection with apical release can be considered a promising technique, which needs further studies to be validated with appropriate comparisons. Full article
(This article belongs to the Special Issue Management of Kidney Stones: Current Scenario and Future Perspectives)
Show Figures

Figure 1

Back to TopTop